ID-1 PROMOTES REENDOTHELIALIZATION IN THE EARLY PHASE AFTER VASCULAR INJURY THROUGH ACTIVATION OF NFKB/SURVIVIN SIGNALING PATHWAY Article Li W., Du D., Li Y. Drug Design, Development and Therapy. Vol. 13. 2019. P. 3799-3811
